Current Report Filing (8-k)
July 31 2019 - 12:38PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2019
BioLargo, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-19709
|
|
65-0159115
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
14921 Chestnut St., Westminster, California
|
|
92683
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: (949)
643-9540
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
BLGO
|
OTCQB
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 7 .01 Regulation FD Disclosure
.
Spokespersons of BioLargo, Inc. (the “Company”) plan to present the
information in the presentation slides attached hereto as Exhibit
99.1 at the Company’s annual stockholder meeting on July 31, 2019
at 10:00 a.m. local time, at the Company’s corporate office located
at 14921 Chestnut St., Westminster, California.
The furnishing of the attached presentation is not an admission as
to the materiality of any information therein. The information
contained in the slides is summary information that is intended to
be considered in the context of more complete information included
in the Company’s filings with the U.S. Securities and Exchange
Commission (the “SEC”) and other public announcements that the
Company has made and may make from time to time by press release or
otherwise. The Company undertakes no duty or obligation to update
or revise the information contained in this report, although it may
do so from time to time as its management believes is appropriate.
Any such updating may be made through the filing of other reports
or documents with the SEC, through press releases or through other
public disclosures. For important information about forward looking
statements, see the information on the first slide under the
heading “Safe Harbor” in Exhibit 99.1 attached hereto.
The information in this Item 7.01 of this Current Report on
Form 8-K and Exhibit 99.1 attached hereto shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, or otherwise subject to the liabilities of
that section or Sections 11 and 12(a)(2) of the Securities Act of
1933, as amended. The information contained in this Item 7.01
and in the presentation attached as Exhibit 99.1 to this Current
Report shall not be incorporated by reference into any filing with
the SEC made by the Company, whether made before or after the date
hereof, regardless of any general incorporation language in such
filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
Date: July 31, 2019
|
|
|
|
BIOLARGO, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Dennis P. Calvert
|
|
|
|
|
|
|
|
|
Dennis P. Calvert
|
|
|
|
|
|
|
|
|
President and Chief Executive Officer
|
|
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Dec 2020 to Jan 2021
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Jan 2020 to Jan 2021